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(2016The earlier the better: When should intrauterine insemination be
done?Intrauterine insemination (IUI) is one of the more widely
used fertility treatments, and often suggested as the first choice
for infertile couples with cervical infertility, mild male factor
infertility, anovulation, mild or minimal endometriosis, and
unexplained infertility with at least one patent fallopian tube
and sufficiently motile sperm.1,2 Although IUI is less invasive
and less expensive than in vitro fertilization, the conception
rate of IUI is limited.3 Meta-analyses reported that IUI with
controlled ovarian stimulation (COS) increases the live birth
rate compared to IUI in the natural cycle.4 However, adverse
events, including ovarian hyperstimulation syndrome and
multiple pregnancy are likely increased in the stimulated IUI
cycle, especially in the high dose gonadotropin cycle.3,5
Additionally, the success rates of IUI generally depend on
various factors, including age of the women, motile sperm
count, type of infertility, semen preparation, the number of
mature follicles, the E2 concentration on the day of human
chorionic gonadotropin (hCG) administration, luteal support,
and the timing of insemination.2,6e10 Because oocytes and
sperm have a limited survival time, correct insemination
timing is imperative. However, optimal timing of the insemi-
nation is still controversial and requires further investigation.
The retrospective cohort study by Yumusak and colleagues
in this issue of the Journal of the Chinese Medical Associa-
tion indicated that different insemination timing was asso-
ciated with pregnancy rate in the certain infertility group
when IUI-COS cycle was applied.10 The authors observed
that early insemination (24 hours following hCG trigger)
achieved a superior clinical pregnancy rate than standard
insemination (36 hours following hCG trigger) in unexplained
infertile patients. However, the benefit was not reflected in
polycystic ovarian syndrome (PCOS) patients. The authors
explained that the main reason for failed pregnancy in
unexplained infertile patients is fertilization defects; there-
fore, early insemination in unexplained infertile couples
probably enhanced the fertilization potential of the insemi-
nated sperm, leading to better pregnancy outcomes. Since
anovulation is the pivotal reason for infertility in PCOS
patients,11 timing of insemination did not affect pregnancy
outcome in PCOS couples. This explanation by the authors
seemed to be reasonable. The authors supposed that earlyx.doi.org/10.1016/j.jcma.2016.07.002
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), http://dx.doi.org/10.1016/j.jcma.2016.07.002insemination might boost the fertilization potential of the
inseminated sperm, and sought to confirm their hypothesis by
investigating whether or not early insemination might
improve pregnancy rate in mild male infertile patients.
Besides, the authors found that later ovulation triggered by
hCG seemed to contribute to better pregnancy rate than ear-
lier hCG trigger. The authors supposed that the result might
stem from higher oocytes quality in later hCG trigger. How-
ever, the Cochrane review revealed that there was no differ-
ence in the pregnancy rate between early and late hCG
trigger.12 Thus, more studies are required to verify the result.
Does early insemination really improve the clinical preg-
nancy rate in the IUI-COS cycle? In fact, it remains a debated
issue. The present study by Yumusak and colleagues provided
us a useful reference,10 but the evidence supporting this
proposition may still be insufficient. First, this was a retro-
spective cohort study with a small sample size, indicating
limited evidence. Second, there have been conflicting results
associated with insemination timing in previous studies.13,14
For example, Wang and colleagues13 conducted a retro-
spective study enrolling 135 couples undergoing IUI-COS
cycles, and found that the efficacy of IUI timing did not dif-
fer at either 24 hours or 36 hours after hCG injection. Another
prospective study performed by Huang et al14 recruited 210
couples with ovulatory dysfunction, unexplained infertility,
and minimal to mild endometriosis. The infertile couples
received an IUI-COS cycle and were treated with IUI 26e28
hours or 36e38 hours after hCG injection. The result also
showed similar pregnancy rates between the two groups when
IUI was performed at either 26e28 hours or 36e38 hours after
hCG injection.14 By contrast, a prospective randomized trial
by Rahman and colleagues15 showed the conflicted data. This
study enrolled 204 couples with mild male factor, unexplained
infertility, and mild endometriosis who underwent 461 IUI-
COS cycles and were randomized to two groups: Group I
(IUI 36 hours after hCG) and Group II (IUI 24 hours after
hCG).15 The result displayed that patients who underwent IUI
36 hours after hCG had marginally better pregnancy rates than
the 24 hour group, although without statistical significance.15
Moreover, the Cochrane review provided no evidence of a
difference in pregnancy rates based upon varying IUI timingsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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insufficient evidence to determine whether there is any dif-
ference in effectiveness between different synchronized
approaches for IUI in subfertile couples.12 The study by
Yumusak and colleagues10 gave us a concept that couples with
recognized causes of infertility possibly obtained a benefit
from specific IUI timing. Taken together, the optimal IUI
timing, especially for certain populations, is still unknown.
Additional large-scale research is needed to determine the
optimal IUI timing among different infertile patients.
In conclusion, IUI remains a popular artificial reproductive
technology worldwide because it is typically less invasive and
less costly than the alternatives. Since the success rates of IUI
are persistently low, many factors that could optimize the
success rates of IUI remain to be defined. We welcome more
large-scale research to determine the optimal IUI timing
among different infertile patients.
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